Educational Sessions: "Genomic and transcriptomic landscape of TNBC"

Educational Sessions: "Genomic and transcriptomic landscape of TNBC"Подробнее

Educational Sessions: 'Genomic and transcriptomic landscape of TNBC'

Educational Sessions: "Optimizing the management of early stage TNBC"Подробнее

Educational Sessions: 'Optimizing the management of early stage TNBC'

Educational Sessions: "Management of special subtypes of TNBC"Подробнее

Educational Sessions: 'Management of special subtypes of TNBC'

Education Session Genomics for Clinical Research and Cancer CareПодробнее

Education Session Genomics for Clinical Research and Cancer Care

Triple Negative Breast Cancer: Predictive and Prognostic Biomarkers for Neo/Adjuvant TherapyПодробнее

Triple Negative Breast Cancer: Predictive and Prognostic Biomarkers for Neo/Adjuvant Therapy

Spotlight Poster Discussion: "Genomic and genetic analysis on metastases"Подробнее

Spotlight Poster Discussion: 'Genomic and genetic analysis on metastases'

Current treatment landscape of triple negative breast cancerПодробнее

Current treatment landscape of triple negative breast cancer

Educational Sessions: "IO beyond TNBC"Подробнее

Educational Sessions: 'IO beyond TNBC'

Genomic and transcriptomic landscape of HER2-low breast cancerПодробнее

Genomic and transcriptomic landscape of HER2-low breast cancer

Digital Spatial Mapping of the Immune Landscape of Triple Negative Breast Cancer...Подробнее

Digital Spatial Mapping of the Immune Landscape of Triple Negative Breast Cancer...

The RNA isoform landscape of cancerПодробнее

The RNA isoform landscape of cancer

Spotlight Session: "Immunotherapy/genomic implications"Подробнее

Spotlight Session: 'Immunotherapy/genomic implications'

Where does immuno-oncology fit in the treatment landscape of TNBC?Подробнее

Where does immuno-oncology fit in the treatment landscape of TNBC?

Promising novel approaches to the treatment of TNBCПодробнее

Promising novel approaches to the treatment of TNBC

New study identifies promising drug combinations for triple negative breast cancer treatmentПодробнее

New study identifies promising drug combinations for triple negative breast cancer treatment

Revolutionising triple negative breast cancer treatmentПодробнее

Revolutionising triple negative breast cancer treatment

New directions in immunotherapy for improving outcomes in TNBCПодробнее

New directions in immunotherapy for improving outcomes in TNBC

The importance of a biomarker-directed approach in triple-negative breast cancerПодробнее

The importance of a biomarker-directed approach in triple-negative breast cancer

Personalizing approaches in early-stage TNBCПодробнее

Personalizing approaches in early-stage TNBC